Champions Oncology, Inc.
CSBR
$5.26
-$0.20-3.66%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -667.00K | -339.00K | 267.00K | -436.00K | -1.84M |
| Total Depreciation and Amortization | 321.00K | 341.00K | 357.00K | 358.00K | 394.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 760.00K | 865.00K | 646.00K | 479.00K | 582.00K |
| Change in Net Operating Assets | -2.41M | -2.21M | -3.01M | 199.00K | 7.73M |
| Cash from Operations | -2.00M | -1.34M | -1.74M | 600.00K | 6.87M |
| Capital Expenditure | -239.00K | -37.00K | -242.00K | -46.00K | -253.00K |
| Sale of Property, Plant, and Equipment | 1.00K | 23.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -238.00K | -14.00K | -242.00K | -46.00K | -253.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -19.00K | -39.00K | -39.00K | -38.00K | -38.00K |
| Issuance of Common Stock | 0.00 | 3.00K | 207.00K | 24.00K | 6.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -19.00K | -36.00K | 168.00K | -14.00K | -32.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.26M | -1.39M | -1.81M | 540.00K | 6.58M |